Bristol-Myers Squibb Company
NYSEBristol-Myers Squibb heads into its July 30 earnings print with options positioning unusually skewed toward calls — a notable shift for a stock that has otherwise drifted quietly lower. The clearest signal this week is in the options market. The put/call ratio has dropped to 0.78, nearly two standard deviations below its 20-day average of 0.86 — a reading close to the 52-week low…
BMY cost to borrow surges to 0.75% — up 101% in one week as short sellers build ahead of July earnings.
Bristol-Myers Squibb heads into its July 30 earnings print with options positioning unusually skewed toward calls — a notable shift for a stock that has otherwise drifted quietly lower. The clearest signal this week is…
The short build in Bristol-Myers Squibb has continued at pace since Tuesday's note. Short interest now stands at 2.32% of free float — up another 20.8% in a single week and 60% over the past month. Bears that were…
Snapshot as of 22 Jun 2026
Bristol-Myers Squibb enters the first week of June in an uncomfortable spot: the stock has shed 6.2% over the past week and 6.5% over the past month, while short sellers have been quietly rebuilding positions at the…
Bristol-Myers Squibb heads into the back half of May with two competing stories pulling in opposite directions: a strategic AI deal with Anthropic announced today, and the fastest build in short interest the stock has…
Bristol-Myers Squibb reports Q1 2026 results on May 5 with the stock down 4% on the month and short sellers quietly building pressure into the event. Short interest has climbed sharply over the past week — up more than…
Bristol-Myers Squibb heads into its April 30 Q1 earnings call with an unusual combination — short sellers are quietly rebuilding positions, options traders are leaning more optimistic than usual, and the Street holds a…
Market Overview Price: $59.39 (as of April 21, 2026) Market Cap: $121.3B Sector: Pharmaceuticals Exchange: NYSE Recent Performance 1-day change: +0.44% 1-week change: +2.26% 1-month change: +3.32% YTD:…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BMY — free to start on ORTEX.
Sign up for free →Open BMY on ORTEX